Search
for

    Sort by

    Research 481–510 of 904

    1. Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps. Open Science Framework · 2026
    2. Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib Dermatologic Therapy · 2026
    3. British Association of Dermatologists living guideline for managing people with alopecia areata 2025 British Journal of Dermatology · 2025
    4. Frontal fibrosing alopecia: follow-up of a brazilian group 2019
    5. Frontal Fibrosing Alopecia: An Observational Single-Center Study of 306 Cases Life · 2023
    6. Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology 2020 · 23 citations
    7. Alopecia Areata of the Nails: Diagnosis and Management Journal of Clinical Medicine · 2024 · 2 citations
    8. Correlation between increased total serum IgE levels and clinical features in alopecia areata patients Frontiers in Immunology · 2025 · 1 citations
    9. Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review Dove Medical Press (Taylor and Francis Group) · 2026
    10. Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations International Journal of Dermatology · 2026
    11. Research progress in the treatment of non-scarring alopecia: mechanism and treatment Frontiers in Pharmacology · 2025
    12. Latanoprost 2025
    13. A systematic review and meta‐synthesis of qualitative studies of alopecia: Managing identity and appearance changes British Journal of Health Psychology · 2026
    14. Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata Dermatology and therapy · 2019 · 55 citations
    15. The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies Frontiers in pharmacology · 2022 · 37 citations
    16. Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis Frontiers in Immunology · 2025
    17. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 18 citations
    18. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 2 citations
    19. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1 New England Journal of Medicine · 2024 · 71 citations
    20. Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib Frontiers in Immunology · 2024 · 5 citations
    21. Alopecia areata Nature Reviews Disease Primers · 2025 · 4 citations
    22. Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años Dermatology Online Journal · 2018
    23. Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study Dermatology · 2026
    24. Biology of the eyelash hair follicle: an enigma in plain sight 2015 · 34 citations
    25. Eyelash Transplantation Using Leg Hair by Follicular Unit Extraction Plastic and reconstructive surgery. Global open · 2015 · 13 citations
    26. Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies Journal of the American Academy of Dermatology · 2024 · 2 citations
    27. PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA Value in Health · 2026
    28. 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries Journal of the American Academy of Dermatology · 2025
    29. Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata Skin · 2023
    30. 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata Journal of The American Academy of Dermatology · 2023